Burst Diagnostics specializes in at-home and point-of-care medical testing through its innovative rapid antigen diagnostics platform. The company has developed a paper-based testing system that offers the sensitivity and specificity comparable to traditional laboratory methods, such as ELISA. This technology allows for easy deployment from laboratories to home use, facilitating efficient testing for a range of conditions, including SARS-CoV-2. The user-friendly design resembles a lateral flow assay, making it accessible to both medical professionals and patients. Burst Diagnostics aims to revolutionize the diagnostic landscape by providing rapid, reliable testing solutions directly in the hands of users.
Star Array is a biomedical technology company based in Singapore that specializes in the development of innovative genetic testing solutions. The company's focus is on ultra-rapid, on-site genetic testing, leveraging advanced nucleic acid amplification and extraction technologies. Star Array is in the process of manufacturing and marketing a range of genetic analyzers, including its flagship product, XDive, along with associated testing kits. Through its novel integrated sample preparation and qPCR processes, Star Array aims to enhance the speed and efficiency of genetic testing, contributing to advancements in the biomedical field.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.